Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
68
VMD Quote, Financials, Valuation and Earnings
Last price:
$7.30
Seasonality move
:
6.43%
Day range:
$7.24 - $7.35
52-week range:
$5.93 - $8.62
Dividend yield:
0%
P/E ratio:
22.06x
P/S ratio:
1.18x
P/B ratio:
2.07x
Volume:
121.8K
Avg. volume:
149.7K
1-year change:
-6.9%
Market cap:
$277.2M
Revenue:
$224.3M
EPS (TTM):
$0.33
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
$72M | $0.10 | 27.85% | 25% | $13.00 |
|
AXGN
Axogen, Inc.
|
$56.9M | $0.07 | 17.39% | 556.06% | $35.44 |
|
ELMD
Electromed, Inc.
|
$16.6M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$9.4M | -$0.11 | -13.8% | -1168.66% | $5.00 |
|
STXS
Stereotaxis, Inc.
|
$8.4M | -$0.06 | 43.22% | -30.79% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
$7.29 | $13.00 | $277.2M | 22.06x | $0.00 | 0% | 1.18x |
|
AXGN
Axogen, Inc.
|
$32.84 | $35.44 | $1.5B | -- | $0.00 | 0% | 7.28x |
|
ELMD
Electromed, Inc.
|
$27.35 | $36.00 | $228.1M | 29.42x | $0.00 | 0% | 3.65x |
|
IRIX
IRIDEX Corp.
|
$1.10 | -- | $18.9M | -- | $0.00 | 0% | 0.36x |
|
MYO
Myomo, Inc.
|
$0.91 | $5.00 | $35M | -- | $0.00 | 0% | 0.90x |
|
STXS
Stereotaxis, Inc.
|
$2.45 | $4.20 | $228.6M | -- | $0.00 | 0% | 7.22x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
15.6% | 0.440 | 9.5% | 0.87x |
|
AXGN
Axogen, Inc.
|
35.99% | -0.858 | 8.25% | 2.56x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
$40.9M | $7M | 9.63% | 10.37% | 9.69% | $10.7M |
|
AXGN
Axogen, Inc.
|
$46M | $1.9M | -1.19% | -1.94% | 3.18% | $1.4M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
Viemed Healthcare, Inc. vs. Competitors
-
Which has Higher Returns VMD or AXGN?
Axogen, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of 1.18%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Axogen, Inc.'s return on equity of -1.94%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M AXGNAxogen, Inc.76.55% $0.01 $188.7M -
What do Analysts Say About VMD or AXGN?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 78.33%. On the other hand Axogen, Inc. has an analysts' consensus of $35.44 which suggests that it could grow by 8.26%. Given that Viemed Healthcare, Inc. has higher upside potential than Axogen, Inc., analysts believe Viemed Healthcare, Inc. is more attractive than Axogen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 AXGNAxogen, Inc.7 0 0 -
Is VMD or AXGN More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Axogen, Inc. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.241%.
-
Which is a Better Dividend Stock VMD or AXGN?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Axogen, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or AXGN?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Axogen, Inc. quarterly revenues of $60.1M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Axogen, Inc.'s net income of $708K. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.06x while Axogen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.18x versus 7.28x for Axogen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.18x 22.06x $71.9M $3.6M AXGNAxogen, Inc.7.28x -- $60.1M $708K
-
Which has Higher Returns VMD or ELMD?
Electromed, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of 12.65%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About VMD or ELMD?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 78.33%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 31.63%. Given that Viemed Healthcare, Inc. has higher upside potential than Electromed, Inc., analysts believe Viemed Healthcare, Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 ELMDElectromed, Inc.4 0 0 -
Is VMD or ELMD More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock VMD or ELMD?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or ELMD?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Electromed, Inc.'s net income of $2.1M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.06x while Electromed, Inc.'s PE ratio is 29.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.18x versus 3.65x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.18x 22.06x $71.9M $3.6M ELMDElectromed, Inc.3.65x 29.42x $16.9M $2.1M
-
Which has Higher Returns VMD or IRIX?
IRIDEX Corp. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of -12.6%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About VMD or IRIX?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 78.33%. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 81.82%. Given that IRIDEX Corp. has higher upside potential than Viemed Healthcare, Inc., analysts believe IRIDEX Corp. is more attractive than Viemed Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 IRIXIRIDEX Corp.0 0 0 -
Is VMD or IRIX More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock VMD or IRIX?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or IRIX?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.06x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.18x versus 0.36x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.18x 22.06x $71.9M $3.6M IRIXIRIDEX Corp.0.36x -- $12.5M -$1.6M
-
Which has Higher Returns VMD or MYO?
Myomo, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of -36.3%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About VMD or MYO?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 78.33%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 449.45%. Given that Myomo, Inc. has higher upside potential than Viemed Healthcare, Inc., analysts believe Myomo, Inc. is more attractive than Viemed Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 MYOMyomo, Inc.4 0 0 -
Is VMD or MYO More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock VMD or MYO?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or MYO?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.06x while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.18x versus 0.90x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.18x 22.06x $71.9M $3.6M MYOMyomo, Inc.0.90x -- $10.1M -$3.7M
-
Which has Higher Returns VMD or STXS?
Stereotaxis, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of -86.59%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About VMD or STXS?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 78.33%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 71.43%. Given that Viemed Healthcare, Inc. has higher upside potential than Stereotaxis, Inc., analysts believe Viemed Healthcare, Inc. is more attractive than Stereotaxis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 STXSStereotaxis, Inc.3 0 0 -
Is VMD or STXS More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock VMD or STXS?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or STXS?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Stereotaxis, Inc. quarterly revenues of $7.5M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.06x while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.18x versus 7.22x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.18x 22.06x $71.9M $3.6M STXSStereotaxis, Inc.7.22x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 3.24% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 1.39% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.1% over the past day.
